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ABSTRACT – To assess and manage Diabetic gastropathy. Diabetic gastropathy is least concern in developing countries but 
many patients receiving oral anti diabetics leads to serious gastric problems. This study involves identification of gastric 
problems and improves compliance, medication adherence among population and also determine the severity of gastric problems 
due to oral hypoglycemic drugs. In our study, women are more effected (54%) than men (46%). Most effected age group is 40-60 
years age with 58% Mild (male-20.9%, female-22.27%) and moderate (male-37.9%, females-39.7%) conditions are the most 
effected in terms of severity. This is due to poor glycemic control and not using proper medication, diet. Treatment should be 
focused on improving gastric symptoms by controlling gastric emptying. Prevention of gastric symptoms by following some 
dietary changes, nutritional and physiological support is effective to patients. 
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I. INTRODUCTION 
Diabetic gastropathy is defined as the abnormality of the 
stomach in diabetic patients. The contractile, electrical, 
sensory functions of stomach are altered. Diabetic gastropathy 
is produced due to hyperglycemic conditions. It is seen in 
diabetic patients. Gastric symptoms like nausea, vomiting, 
regurgitation, heartburn, early satiety, postprandial fullness, 
bloating and abdominal pain/discomfort are common. 
  Delayed gastric emptying time is key factor for 
occurrence of gastropathy. It impacts on nutrition, 
gastrointestinal symptoms, glycemic control, and drug 
absorption. Diet and glucose control are effective in 
management of gastropathy. Exact pathophysiology of 
diabetic gastropathy remains unclear. Treatment focuses on 
improving gastric emptying, controlling symptoms and 
glycemic control. Prokinetic drug therapy is also used in the 
management of gastric symptoms. Psychological support and 
nutrition are equally important in patient outcome. Glycemic 
control is foremost in the management. 
Long standing, poorly controlled diabetes leads to diabetic 
gastropathy. Long term use of medications in diabetic patients 
results in delayed gastric emptying time which results in 
diabetic gastropathy. The common symptoms associated with 
gastropathy are nausea, vomiting, abdominal pain and 
bloating. Delay in gastric emptying time results in poor 
glycemic control, poor nutrition, and dehydration. Diabetic 
gastropathy can be managed by maintaining gastric emptying 
time and good glycemic control with dietary modifications. 
Early modifications in glycemic control are effective in 
prevention of gastropathy. Prokinetic agents along with anti-
emetics and antihistamines may be helpful to relieve the 
symptoms of gastropathy. 
II. METHODOLOGY 
It is a multi-centered prospective observational study designed 
to assess and manage Diabetic Gastropathy. The present study 
was conducted at tertiary care hospital in Hanamkonda, 
Warangal covering outpatients. This study was conducted for 
a period of     6 months involving around 1000 subjects. Male 
and female subjects of age group 20-80 with diabetes mellitus 
are taken for the study based on inclusion and exclusion 
criteria. 
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III. SELECTION CRITERIA: 
A. Inclusion Criteria 
• Patients from 20-80 years of age. 
• Patients receiving hypoglycemic agents for at least 3 
months and continuing treatment. 
• Patients on treatment with single or multiple 
hypoglycemic agents. 
• Patients are receiving only oral hypoglycemic agent 
therapy. 
B. Exclusion Criteria 
• Infants, neonates, adolescents. 
• Noncompliance of disease 
• Other pathological disease states 
• Immunocompromised patients 
• Pregnancy.  
IV.TABLES 
Table 1: Gender Wise Distribution 
Gender No Of Patients 
Male 456 (46%) 
Female 4%) 
 
Table 2: Based on Age 
S. No Age Patients 
1 20-40 278 
2 41-60 582 
3 61-80 140 
 
Table 3: Based on Severity Score 
  Male Female Total 
None 0 82 (17.9%) 97 (17.8%) 179 
Very Mild 0-16 53 (11.6%) 62 (11.3%) 115 
Mild 17-32 95 (20.9%) 121 (22.2%) 216 
Moderate 33-48 173 (37.9%) 200 (39.7%) 373 
Severe 49-64 53 (11.6%) 64 (11.7%) 117 
  456 544  
 
Table 4: Based on Duration 
 Male Female Total 
<1  Year 83(18.20%) 93(16.78%) 176 
1-5 Years 217(47.58%) 260(46.93%) 477 
06-10 
Years 
94(20.6%) 131(23.64%) 225 
11-15 
Years 
31(6.79%) 34(6.13%) 65 
16-20 
Years 
31(6.79%) 36(6.49%) 67 
 456 554  
 
Table 5: Based on Co-Morbidity Conditions: 
S. 
No 
Disease Male Female Total 
1 Hypertension 141 (79.2%) 118(38.8%) 259 
2 Hypothyroidism 21 (11.7%) 109(35.8%) 130 








4 Hyperthyroidism 2 (1.1%) 7(2.3%) 9 




Chart 1. Gender Wise Distribution 
 
Chart 2. Based On Age 
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Chart 3. Based On Severity Score 
 
 
Chart 4. Based On Duration 
 
Chart 5. Based On Co-Morbidity Conditions 
VI. DISCUSSION 
Diabetic gastropathy is the stomach abnormality due to 
hyperglycemic condition. In this study assessment and 
management of diabetic gastropathy is focused. This is a 
prospective observational study. It includes 1000 patients with 
age group between 20-80 years. Diabetic patients (Type-II) 
who are suffering with at least 2-3 gastric symptoms for few 
weeks are considered. In six months, study parameters like 
age, gender, co-morbid conditions, duration of diabetes, 
severity of symptoms are analyzed based on patient response. 
The most common co-morbid conditions included in this study 
are hypertension, hypothyroidism, and hyperthyroidism. 
Laboratory parameters like blood glucose levels (fasting, 
postprandial and random) are analyzed. Other parameters like 
social history, past medical history, family history, previous 
illness and current medication are also recorded. A 
questionnaire was answered by the patients regarding severity 
of symptoms and values/scores are noted. The PAGI-SYM 
scale is a symptom severity instrument which consists of a 
questionnaire (i.e,16 questions and 5 subscales) to measure the 
gastrointestinal symptoms severity in diabetic patients. Based 
on severity score from PAGI-SYM scale severity is concluded 

















Heart burn (burning pain in chest or throat 
during the day) 
      
Heart burn (while lying down)       
Regurgitation or reflux (during the day)       
Regurgitation (while lying down)       
Nausea       
Vomiting       
Upper abdominal pain/discomfort       
Stomach fullness       
Loss of appetite       
Lower abdominal pain/discomfort       
Feeling discomfort in chest       
Bitter or acid/sour taste in your mouth       
Bloating       
Not able to finish a normal sized meal       
Feeling excessive after meals       
Other problems explained       
 
VII. Results 
Table 1.  Shows out of 1000 patients 460 (46%) are males and 
540 (54%) are females. 
Table 2. Indicates the patients, we considered of age groups 
between 20-80 years. In this 28% are affected at the age group 
of 20-40 years, 58% are affected at the age group of 40-60 
years and 14% are affected at the age group of 60-80 years. 
Table 3. Reveals the information based on severity scores. In 
very mild condition – 11.6% males and 11.3% females are 
affected. In mild condition – 20.9% males and 22.2% females 
are affected. In moderate condition – 37.9% males and 39.7% 
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females are affected. In severe condition – 11.6% males and 
11.7 % females are affected. 
Table 4. Explains the information based on duration of 
diabetes. In patients with duration less than 1 year 18.20% 
males and 16.78% females are affected with total of 34.98%. 
In 1 to 5 years of duration, 47.58% males and 46.93% females 
with a total of 94.5% are affected. In 6 to 10 years of duration, 
20.6% males and 23.64% females with a total of 44.24% are 
affected. In 11 to 15 years of duration, 6.79% males and 
6.13%females with a total of 12.92% are affected. In 16 to 20 
years of duration, 6.79% males and 6.49% females with a total 
of 13.28% are affected. 
Table 5. Gives the information on co-morbid conditions, 
79.2% males and 38.8% females with hypertension is affected. 
11.7% males and 35.8% females with hypothyroidism. 1.1% 
males and 2.3% females with hyperthyroidism. 7.86% males, 
22.3% females have both hypertension and hypothyroidism. 
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